Rationale and methods of the IDOMENEO health outcomes of the peripheral arterial disease revascularisation study in the GermanVasc registry
Abstract
Abstract.Background: Atherosclerotic disease of the lower extremity arteries (PAD) remains a significant burden on global healthcare systems with increasing prevalence. Various guidelines on the diagnosis and treatment of patients with PAD are available but they often lack a sufficient evidence base for high-grade recommendations since randomized and controlled trials (RCT) remain rare or are frequently subject to conflicts of interest. This registry trial aims to evaluate the outcomes of catheter-based endovascular revascularisations vs. open-surgical endarterectomy vs. bypass surgery for symptomatic PAD on medical and patient-reported outcomes. Methods and design: The study is a prospective non-randomized multicentre registry trial including invasive revascularisations performed in 10 000 patients treated for symptomatic PAD at 30 to 40 German vascular centres. All patients matching the inclusion criteria are consecutively included for a recruitment period of six months (between May and December 2018) or until 10 000 patients have been included in the study registry. There are three follow-up measures at three, six, and 12 months. Automated completeness and plausibility checks as well as independent site visit monitoring will be performed to assure high internal and external validity of the study data. Study endpoints include relevant major cardiovascular and limb events and patient-reported outcomes from two Delphi studies with experts in vascular medicine and registry-based research. Discussion: It remains unclear if results from RCT can reflect daily treatment practice. Furthermore, great costs and complexity make it challenging to accomplish high quality randomized trials in PAD treatment. Prospective registry-based studies to collect real-world evidence can help to overcome these limitations.
Literature
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329–40.
Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010. Glob Heart. 2014;9:145–158.e21.
Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis. Eur Heart J. 2013;34:2706–14.
Krankenhausdiagnosestatistik. In. URL: https://www.gbe-bund.de/: Statistisches Bundesamt DeStatis; 2014, Gesundheitsberichterstattung des Bundes.
.IDOMENEO – Ist die Versorgungsrealität in der Gefäßmedizin Leitlinien- und Versorgungsgerecht? Gefässchirurgie. 2017;22:41–7.
[Guideline recommendations and quality indicators for invasive treatment of peripheral arterial disease in Germany : The IDOMENEO study for quality improvement and research in vascular medicine]. Bundesgesundheitsbl. 2018; 61:218–23.
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39:763–816.
German guideline on the diagnosis and treatment of peripheral artery disease – a comprehensive update 2016. VASA. 2017;46:79–86.
.S3-Leitlinie PAVK – Diagnostik, Therapie und Nachsorge der peripheren arteriellen Verschlusskrankheit. VASA. 2016;45:1–96.Randomized trials or population-based registries. Eur J Vasc Endovasc Surg. 2007; 34:253–6.
.Publication of Vascular Surgical Registry Data: Strengths and Limitations. Eur J Vasc Endovasc Surg. 2017;54:788.
.Percutaneous endovascular treatment of infrainguinal PAOD: Results of the PSI register study in 74 German vascular centers. Gefasschirurgie. 2017;22:17–27.
.Rationale and design of the RECording COurses of vasculaR Diseases registry (RECCORD registry). VASA. 2017;46:262–7.
Results of peripheral bypass surgery in patients with critical limb ischemia (CRITISCH registry). Gefässchirurgie. 2016;21:71–9.
.Einführung des GermanVasc. Gefässchirurgie. 2014;19:403–11.
.[Clinical registers in the twenty-first century : Balancing act between data protection and feasibility?]. Chirurg. 2017;88:944–9.
.The Challenge of Data Privacy Compliant Registry Based Research. Eur J Vasc Endovasc Surg. 2018;55:601–2.
.Robustness issues in multilevel regression analysis. Statistica Neerlandica. 2004;58:127–37.
.International Consortium of Vascular Registries Consensus Recommendations for Peripheral Revascularization Registry Data Collection. Eur J Vasc Endovasc Surg. 2018;Epub ahead of print.
Indicators of Outcome Quality in Peripheral Arterial Disease Revascularisations – A Delphi Expert Consensus. VASA. 2018;47: https://econtent.hogrefe.com/doi/10.1024/0301- 1526/a000720.
Linking Clinical Variables With Health-Related Quality of Life. JAMA. 1995;273:59–65.
.The COMET Handbook: version 1.0. Trials. 2017;18:280.
Lebensqualität und Psychosomatik bei PAVK. Gefässchirurgie. 2017;22:157–8.
.Patient-reported outcome measures in patients with peripheral arterial disease: a systematic review of psychometric properties. Health Qual Life Outcomes. 2016;14:161.
Assessment of functional status and quality of life in claudication. J Vasc Surg. 2011;53:1410–21.
Trans-Atlantic Conference on Clinical Trial Guidelines in PAOD (Peripheral Arterial Occlusive Disease) Clinical Trial Methodology. Eur J Vasc Endovasc Surg. 1999;18:253–65.
.Quality of life in patients with intermittent claudication. Gefasschirurgie. 2017;22:159–64.
.Assessing the quality of available patient reported outcome measures for intermittent claudication: a systematic review using the COSMIN checklist. Eur J Vasc Endovasc Surg. 2015;49: 316–34.
.A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.
.Development and evaluation of the Walking Estimated-Limitation Calculated by History questionnaire in patients with claudication. J Vasc Surg. 2013;58:981–8.
An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ-4. Psychosomatics. 2009;50:613–21.
.Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:1425–43.
National Clinical Guideline Centre (UK) . Lower Limb Peripheral Arterial Disease: Diagnosis and Management [Internet]. London: Royal College of Physicians (UK); 2012 Aug. (NICE Clinical Guidelines, No. 147.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK299071/.Registry and health insurance claims data in vascular research and quality improvement. VASA. 2017;46:11–5.
.The quality of a registry based study depends on the quality of the data – without validation, it is questionable. Eur J Vasc Endovasc Surg. 2017;53:611–2.
.Klinische Register im 21. Jahrhundert – Ein Spagat zwischen Datenschutz und Machbarkeit? Chirurg. 2017;88:944–9.
.